Literature DB >> 12419775

Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase.

Monica K Cheng1, John C McGiff, Mairead A Carroll.   

Abstract

20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 omega-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimulates the renin-angiotensin system and induces renal cortical COX-2 expression, we examined 20-HETE release from renal arteries (interlobar and arcuate and interlobular arteries) obtained from 6- to 7-wk-old male Sprague-Dawley rats fed either normal salt (0.4% NaCl) or LS (0.05% NaCl) diets for 10 days. With normal salt intake, the levels of 20-HETE recovered were similar in arcuate and interlobular arteries and interlobar arteries: 30.1 +/- 8.5 vs. 24.6 +/- 5.3 ng. mg protein(-1). 30 min(-1), respectively. An LS diet increased 20-HETE levels in the incubate of either arcuate and interlobular or interlobar renal arteries only when COX was inhibited. Addition of indomethacin (10 microM) to the incubate of arteries obtained from rats fed an LS diet resulted in a two- to threefold increase in 20-HETE release from arcuate and interlobular arteries, from 39.1 +/- 13.2 to 101.8 +/- 42.6 ng. mg protein(-1). 30 min(-1) (P < 0.03), and interlobar arteries, from 31.7 +/- 15.1 to 61.9 +/- 29.4 ng. mg protein(-1). 30 min(-1) (P < 0.05) compared with release of 20-HETE when COX was not inhibited. An LS diet enhanced vascular expression of cytochrome P-4504A and COX-2 in arcuate and interlobular arteries; COX-1 was unaffected. Metabolism of 20-HETE by COX is proposed to represent an important regulatory mechanism in setting preglomerular microvascular tone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419775     DOI: 10.1152/ajprenal.00239.2002

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  11 in total

Review 1.  Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

Authors:  Tilo Grosser; Susanne Fries; Garret A FitzGerald
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

2.  Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion Injury.

Authors:  Yoshikazu Muroya; Fan Fan; Kevin R Regner; John R Falck; Michael R Garrett; Luis A Juncos; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

3.  N-acetyl-Ser-Asp-Lys-Pro inhibits interleukin-1β-mediated matrix metalloproteinase activation in cardiac fibroblasts.

Authors:  Nour-Eddine Rhaleb; Saraswati Pokharel; Umesh C Sharma; Hongmei Peng; Edward Peterson; Pamela Harding; Xiao-Ping Yang; Oscar A Carretero
Journal:  Pflugers Arch       Date:  2013-05-08       Impact factor: 3.657

4.  A synthetic epoxyeicosatrienoic acid analogue prevents the initiation of ischemic acute kidney injury.

Authors:  Uwe Hoff; Gordana Bubalo; Mandy Fechner; Maximilian Blum; Ye Zhu; Andreas Pohlmann; Jan Hentschel; Karen Arakelyan; Erdmann Seeliger; Bert Flemming; Dennis Gürgen; Michael Rothe; Thoralf Niendorf; Vijaya L Manthati; John R Falck; Michael Haase; Wolf-Hagen Schunck; Duska Dragun
Journal:  Acta Physiol (Oxf)       Date:  2019-06-02       Impact factor: 6.311

5.  Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies.

Authors:  Vandana Hirani; Anton Yarovoy; Anita Kozeska; Ronald P Magnusson; Jerome M Lasker
Journal:  Arch Biochem Biophys       Date:  2008-07-16       Impact factor: 4.013

6.  Failure to upregulate the adenosine2A receptor-epoxyeicosatrienoic acid pathway contributes to the development of hypertension in Dahl salt-sensitive rats.

Authors:  Elvira L Liclican; John C McGiff; John R Falck; Mairéad A Carroll
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-01

7.  Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors.

Authors:  M K Cheng; A B Doumad; H Jiang; J R Falck; J C McGiff; M A Carroll
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

8.  Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease.

Authors:  Pietro Minuz; Houli Jiang; Cristiano Fava; Lucia Turolo; Stefania Tacconelli; Marco Ricci; Paola Patrignani; Alberto Morganti; Alessandro Lechi; John C McGiff
Journal:  Hypertension       Date:  2008-03-31       Impact factor: 10.190

Review 9.  Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target.

Authors:  Osama H Elshenawy; Sherif M Shoieb; Anwar Mohamed; Ayman O S El-Kadi
Journal:  Pharmaceutics       Date:  2017-02-20       Impact factor: 6.321

10.  17β Estradiol Modulates Perfusion Pressure and Expression of 5-LOX and CYP450 4A in the Isolated Kidney of Metabolic Syndrome Female Rats.

Authors:  A M Zúñiga-Muñoz; V Guarner Lans; E Soria-Castro; E Diaz-Diaz; R Torrico-Lavayen; E Tena-Betancourt; I Pérez-Torres
Journal:  Int J Endocrinol       Date:  2015-09-27       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.